Deutsche Bank
RDHL

Deutsche Bank’s Redhill Biopharma RDHL Stock Holding History

Deutsche Bank’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19
Closed -$172K – 5363
2018
Q3 		$172K Buy
+19
New +$155K ﹤0.01% 4298
2017
Q3 		– Sell
-21
Closed -$181K – 5044
2017
Q2 		$181K Sell
21
-6
-22% -$57.7K ﹤0.01% 3977
2017
Q1 		$257K Buy
27
+13
+93% +$130K ﹤0.01% 3455
2016
Q4 		$141K Buy
14
+11
+367% +$132K ﹤0.01% 3887
2016
Q3 		$44K Buy
+3
New +$42K ﹤0.01% 4261
2016
Q2 		– Sell
-1
Closed -$11.6K – 5315
2016
Q1 		$10K Buy
+1
New +$10.5K ﹤0.01% 4833
2015
Q4 		– Hold
0
– -$3K – 5390
2015
Q3 		– Sell
-11
Closed -$163K – 5087
2015
Q2 		$190K Buy
11
+10
+1,000% +$159K ﹤0.01% 3917
2015
Q1 		$14K Buy
+1
New +$14.2K ﹤0.01% 4747

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Deutsche Bank's RDHL Position: Q4 2018 in Review

Deutsche Bank sold out of Redhill Biopharma (RDHL) in Q4 2018, closing a stake of 19 shares — an estimated $172K sold.

Deutsche Bank first reported a position in RDHL in Q1 2015 and held it in 8 quarters. The position peaked at $257K in Q1 2017. 36 funds tracked by Wall St. Rank hold RDHL as of Q4 2018.

  • Deutsche Bank reported no remaining Redhill Biopharma position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 19 Redhill Biopharma shares in Q4 2018, an estimated $172K.
  • Deutsche Bank first reported a position in Redhill Biopharma in Q1 2015 and held it in 8 quarters.
  • Deutsche Bank's Redhill Biopharma position peaked at $257K in Q1 2017.
  • 36 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.